These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
359 related items for PubMed ID: 23094050
1. APE1/Ref-1 regulates STAT3 transcriptional activity and APE1/Ref-1-STAT3 dual-targeting effectively inhibits pancreatic cancer cell survival. Cardoso AA, Jiang Y, Luo M, Reed AM, Shahda S, He Y, Maitra A, Kelley MR, Fishel ML. PLoS One; 2012; 7(10):e47462. PubMed ID: 23094050 [Abstract] [Full Text] [Related]
4. Impact of APE1/Ref-1 redox inhibition on pancreatic tumor growth. Fishel ML, Jiang Y, Rajeshkumar NV, Scandura G, Sinn AL, He Y, Shen C, Jones DR, Pollok KE, Ivan M, Maitra A, Kelley MR. Mol Cancer Ther; 2011 Sep; 10(9):1698-708. PubMed ID: 21700832 [Abstract] [Full Text] [Related]
6. Blocking HIF signaling via novel inhibitors of CA9 and APE1/Ref-1 dramatically affects pancreatic cancer cell survival. Logsdon DP, Shah F, Carta F, Supuran CT, Kamocka M, Jacobsen MH, Sandusky GE, Kelley MR, Fishel ML. Sci Rep; 2018 Sep 13; 8(1):13759. PubMed ID: 30214007 [Abstract] [Full Text] [Related]
7. Ape1 regulates WNT/β-catenin signaling through its redox functional domain in pancreatic cancer cells. Jiang S, Zhu L, Tang H, Zhang M, Chen Z, Fei J, Han B, Zou GM. Int J Oncol; 2015 Aug 13; 47(2):610-20. PubMed ID: 26081414 [Abstract] [Full Text] [Related]
9. Suppression of choroidal neovascularization through inhibition of APE1/Ref-1 redox activity. Li Y, Liu X, Zhou T, Kelley MR, Edwards PA, Gao H, Qiao X. Invest Ophthalmol Vis Sci; 2014 Jun 26; 55(7):4461-9. PubMed ID: 24970265 [Abstract] [Full Text] [Related]
10. Inhibition of the redox function of APE1/Ref-1 in myeloid leukemia cell lines results in a hypersensitive response to retinoic acid-induced differentiation and apoptosis. Fishel ML, Colvin ES, Luo M, Kelley MR, Robertson KA. Exp Hematol; 2010 Dec 26; 38(12):1178-88. PubMed ID: 20826193 [Abstract] [Full Text] [Related]
15. Specific inhibition of the redox activity of ape1/ref-1 by e3330 blocks tnf-α-induced activation of IL-8 production in liver cancer cell lines. Cesaratto L, Codarin E, Vascotto C, Leonardi A, Kelley MR, Tiribelli C, Tell G. PLoS One; 2013 Dec 26; 8(8):e70909. PubMed ID: 23967134 [Abstract] [Full Text] [Related]
16. Knock-in reconstitution studies reveal an unexpected role of Cys-65 in regulating APE1/Ref-1 subcellular trafficking and function. Vascotto C, Bisetto E, Li M, Zeef LA, D'Ambrosio C, Domenis R, Comelli M, Delneri D, Scaloni A, Altieri F, Mavelli I, Quadrifoglio F, Kelley MR, Tell G. Mol Biol Cell; 2011 Oct 26; 22(20):3887-901. PubMed ID: 21865600 [Abstract] [Full Text] [Related]
17. Identification of Novel Pathways Regulated by APE1/Ref-1 in Human Retinal Endothelial Cells. Mijit M, Liu S, Sishtla K, Hartman GD, Wan J, Corson TW, Kelley MR. Int J Mol Sci; 2023 Jan 06; 24(2):. PubMed ID: 36674619 [Abstract] [Full Text] [Related]
18. Design and synthesis of novel quinone inhibitors targeted to the redox function of apurinic/apyrimidinic endonuclease 1/redox enhancing factor-1 (Ape1/ref-1). Nyland RL, Luo M, Kelley MR, Borch RF. J Med Chem; 2010 Feb 11; 53(3):1200-10. PubMed ID: 20067291 [Abstract] [Full Text] [Related]
19. NMR studies reveal an unexpected binding site for a redox inhibitor of AP endonuclease 1. Manvilla BA, Wauchope O, Seley-Radtke KL, Drohat AC. Biochemistry; 2011 Dec 06; 50(48):10540-9. PubMed ID: 22032234 [Abstract] [Full Text] [Related]
20. Downregulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 enhances the sensitivity of human pancreatic cancer cells to radiotherapy in vitro. Chen S, Xiong G, Wu S, Mo J. Cancer Biother Radiopharm; 2013 Mar 06; 28(2):169-76. PubMed ID: 23268706 [Abstract] [Full Text] [Related] Page: [Next] [New Search]